3an erectile function be predicted after prostate cancer Ireatment？

作     者：Frances M Alba Run Wang 

作者机构：Division of Urology University of Texas Medical School at Houston and Department of Urology University of Texas Medical School at Houston Houston TX 77030 USA University of Texas MD Anderson Cancer Center Houston TX 77030 USA 

出 版 物：《Asian Journal of Andrology》 (亚洲男性学杂志（英文版）)

年 卷 期：2012年第14卷第1期

页      面：134-135页

核心收录：

学科分类：090603[农学-临床兽医学] 0710[理学-生物学] 1002[医学-临床医学] 07[理学] 08[工学] 09[农学] 0906[农学-兽医学] 071007[理学-遗传学] 0901[农学-作物学] 0836[工学-生物工程] 090102[农学-作物遗传育种] 

主　　题：Prostate cancer prostate-specific antigen screening radical prostatecomy external beam radiation therapy brachytehrapy HRQOL 

摘      要：Prostate cancer （PCa） is the most common solid-organ cancer in American males and the second most common cause of cancer-related death in men. With the advent of prostate-specific antigen screening, death from PCa continues to decline. However, recent evidence suggests that there is now a trend towards increasing incidence.1 Current screening strategies result in increased incidence of low-risk PCa and importantly, the diagnosis of PCa is becoming more common in younger patients.2 The majority of early-stage PCa patients have a high likelihood of disease free survival after treatment.